1.Study on mechanism of Chanbao zhichuang suppository in treating hemorrhoids based on network pharmacology and metabolomics
Chunfeng GUO ; Xin JIANG ; Ruyang CHENG ; Shumin LIU ; Chunxiang XIE ; Fang LU
China Pharmacy 2025;36(13):1622-1628
		                        		
		                        			
		                        			OBJECTIVE To explore the mechanism of improvement effect of Chanbao zhichuang suppository (CBZCS) on hemorrhoids in rats through network pharmacology and metabolomics. METHODS A hemorrhoid model was established by subcutaneous injection of rhododendron oil to induce anal swelling. SD rats were divided into blank group (NC group, 0.32 g/kg vaseline), model group (Model group, 0.32 g/kg vaseline), CBZCS low-, medium-, and high-dose groups (CBZCS-L, CBZCS- M, CBZCS-H groups, with dosages of 0.16, 0.32, and 0.64 g/kg respectively), and Mayinglong musk hemorrhoids suppository group (Positive group, 0.32 g/kg), with 9 rats in each group. Anal administration was performed at 6, 12, 24, 48, and 72 hours after modeling. After the last administration, the pathological changes of the anal tissues in rats were observed, and the serum levels of interleukin-6 (IL-6) and tumor necrosis factor-α (TNF-α) in rats were detected. Differential metabolite analysis and enrichment analysis were conducted by metabolomics methods, and the target proteins of CBZCS in treating hemorrhoids were obtained by network pharmacology. The core metabolic pathways were screened by interaction and enrichment analysis of differential metabolites and proteins, and the core proteins were experimentally verified. RESULTS Compared with the NC group, the anal tissues of the Model group showed obvious lesions, and the levels of IL-6 and TNF- α in the serum were significantly increased (P<0.05); compared with the Model group, the pathological damage of the anal tissues in the treatment groups was alleviated to varying degrees, and serum levels of IL-6 in CBZCS-H group, CBZCS-M group, and Positive group as well as serum levels of TNF-α in CBZCS-H group were significantly reduced (P<0.05). The metabolomics results showed that 34 differential metabolites were screened from the anal tissues of rats, and 22 of them showed a return after CBZCS administration. The differential metabolites mainly enriched in arachidonic acid metabolism, histidine metabolism, and glycerophospholipid metabolism. Through the network pharmacology, 138 intersection genes of CBZCS against hemorrhoids were determined. The analysis results showed that differential metabolites and target proteins were mainly enriched in the arachidonic acid metabolism pathway, and the regulation of this pathway might be related to cyclooxygenase-2 (COX-2), Myc proto-oncogene protein (c-MYC), cytochrome P450 1B1 (CYP1B1), interleukin-1β (IL-1β), and IL-6 protein expression. The experimental verification results showed that the expression levels of key proteins (COX-2, c-MYC, CYP1B1, IL-6, IL-1β) in the anal tissues of the Model group were significantly higher than those in the NC group (P<0.05), and the levels of the above proteins in the anal tissues of CBZCS-H group and Positive group were significantly lower than those in the Model group (P<0.05). CONCLUSIONS The mechanism of CBZCS in treating hemorrhoids may be to inhibit the expression of COX-2, c-MYC and CYP1B1 proteins, thereby inhibiting arachidonic acid metabolism and reducing the release of inflammatory factors IL-6 and IL-1β.
		                        		
		                        		
		                        		
		                        	
2.Analysis on the operation effect of China’s drug complaints and reporting system
Yang LIU ; Haihong JIANG ; Xin YUAN
China Pharmacy 2025;36(14):1697-1702
		                        		
		                        			
		                        			OBJECTIVE To evaluate the operation effect of the drug complaints and reporting system in China, and put forward the suggestions for improving the drug supervision system and enhancing the national drug scientific supervision capacity. METHODS The statistical data of drug supervision from 2012 to 2023 and the complaint data of various provinces and 7 third- party platforms of drug online sales from National 12315 Consumer Complaint Information Disclosure Platform from 2023 to 2024 were collected. The operation effect of drug complaints and reporting system was analyzed from the dimensions of public participation, public satisfaction, case handling efficiency and quality, social effect and risk early warning ability. RESULTS From 2012 to 2019, the acceptance of drug complaints and reporting fluctuated greatly, and the number of drug complaints and reporting cases showed a downward trend as a whole, but the public satisfaction was high and the closure rate continued to increase. From 2023 to 2024, the top five provinces in terms of the number of drug complaints were Guangdong, Henan, Zhejiang, Shandong and Shanghai. Drug complaints in the online platform mainly involved Chinese and Western medicines, traditional Chinese medicines and Chinese herbal medicines sold on the network platforms of Pinduoduo, Jingdong and Taobao. The complaints focused on quality and after-sales service, and there were significant differences in the proportion of mediation agreements in drug complaint cases. From 2021 to 2024, the drug regulatory authorities investigated and dealt with 11 typical cases of online sales violations through complaint and reporting clues. CONCLUSIONS The drug complaints and reporting system in China runs smoothly. It is suggested to further use the data of National 12315 Consumer Complaint Information Disclosure Platform to strengthen the monitoring of key areas and network platforms, and urge enterprises to implement the main responsibility, so as to improve the quality and safety of drugs and ensure the safety of public medication.
		                        		
		                        		
		                        		
		                        	
3.Case report and literature analysis of Mycobacterium iranicum infection
Yewen ZHANG ; Chengling LUO ; Wengao JIANG ; Min CHEN ; Qian DU ; Wei YAO ; Songqing LIU ; Xin XI
China Pharmacy 2025;36(15):1931-1935
		                        		
		                        			
		                        			OBJECTIVE To offer a reference for the treatment of Mycobacterium iranicum infection by analyzing the diagnosis and management of a single case alongside literature-reported cases. METHODS Through case report and literature reviews, this study synthesized the clinical features, therapeutic regimens, and patient outcomes of those infected with M. iranicum. RESULTS In the single case documented in this report, subsequent to clinical pharmacists’ involvement in the consultation, the patient was prescribed a therapeutic regimen comprising levofloxacin (0.5 g, qd, ivgtt)+Clarithromycin sustained-release tablets (1 000 mg, qd, po) + Ethambutol tablets (0.75 g, qd, po). The patient exhibited clinical improvement and was discharged after treatment. This article integrated 12 published studies, encompassing 13 patients (7 male and 6 female), of whom 69.23% were aged ≥50 years. Patients infected with M. iranicum exhibited non-specific clinical manifestations and imaging features, with pulmonary infection as the primary presentation. Antimicrobial susceptibility test revealed that M. iranicum was susceptible to multiple agents, including amikacin, clarithromycin, linezolid, and ethambutol. The three-drug combination therapy was the most frequently employed regimen. In terms of clinical outcomes, there were 9 cases (69.23%) of clinical cure, 3 cases (23.08%) of bacteriological negativity conversion, and 1 case (7.69%) of treatment failure. CONCLUSIONS For M. iranicum infection, a triple-drug therapeutic regimen consisting of three agents with distinct mechanisms of action selected from amikacin, clarithromycin, moxifloxacin, levofloxacin, minocycline, ethambutol, and other relevant drugs may represent a relatively optimal strategy.
		                        		
		                        		
		                        		
		                        	
4.Construction and practice of an intelligent management system for preoperative anemia based on multidisciplinary collaboration
Cuihua TAO ; Yingsen HU ; Xin LIAO ; Hongling TANG ; Liyuan JIANG ; Jiangshang SUN ; Man MOU ; Xiaohui LIU ; Yong HE ; Jie YANG
Chinese Journal of Blood Transfusion 2025;38(9):1242-1247
		                        		
		                        			
		                        			Objective: To improve the efficiency and standardization of preoperative anemia diagnosis and treatment by establishing a systematic intelligent management platform for preoperative anemia. Methods: A multidisciplinary collaborative model was adopted to develop a preoperative anemia management system that integrates intelligent early warning, standardized treatment pathways, and quality control. The system utilizes natural language processing technology to automatically capture laboratory data and establish evidence-based medical decision support functions. A pre-post study design was employed to compare changes in preoperative anemia screening rates, preoperative anemia intervention rates, reasonable use of iron supplements, and perioperative red blood cell transfusion rates before and after system implementation. Results: After system implementation, the standardization of anemia diagnosis and treatment significantly improved: 1) Screening effectiveness: The anemia screening rate increased to 50.00% (an increase of 27.24%); 2) Intervention effectiveness: The anemia treatment rate rose to 56.30% (an increase of 14.02%); 3) Treatment standardization: The reasonable use rate of iron supplements increased to 55.33% (an increase of 21.02%); the red blood cell transfusion rate decreased to 18.29% (a decrease of 4.07%), and the amount of red blood cell transfusions was reduced by 291 units. Conclusion: This system achieves full-process management of preoperative anemia through information technology, significantly enhancing the standardization of diagnosis and treatment as well as intervention effectiveness, providing an effective solution for perioperative anemia management.
		                        		
		                        		
		                        		
		                        	
5.Study on the modeling method of general model of Yaobitong capsule intermediates quality analysis based on near infrared spectroscopy
Le-ting SI ; Xin ZHANG ; Yong-chao ZHANG ; Jiang-yan ZHANG ; Jun WANG ; Yong CHEN ; Xue-song LIU ; Yong-jiang WU
Acta Pharmaceutica Sinica 2025;60(2):471-478
		                        		
		                        			
		                        			 The general models for intermediates quality analysis in the production process of Yaobitong capsule were established by near infrared spectroscopy (NIRS) combined with chemometrics, realizing the rapid determination of notoginsenoside R1, ginsenoside Rg1, ginsenoside Re, ginsenoside Rb1, ginsenoside Rd and moisture. The spray-dried fine powder and total mixed granule were selected as research objects. The contents of five saponins were determined by high performance liquid chromatography and the moisture content was determined by drying method. The measured contents were used as reference values. Meanwhile, NIR spectra were collected. After removing abnormal samples by Monte Carlo cross validation (MCCV), Monte Carlo uninformative variables elimination (MC-UVE) and competitive adaptive reweighted sampling (CARS) were used to select feature variables respectively. Based on the feature variables, quantitative models were established by partial least squares regression (PLSR), extreme learning machine (ELM) and ant lion optimization least squares support vector machine (ALO-LSSVM). The results showed that CARS-ALO-LSSVM model had the optimum effect. The correlation coefficients of the six index components were greater than 0.93, and the relative standard errors were controlled within 6%. ALO-LSSVM was more suitable for a large number of samples with rich information, and the prediction effect and stability of the model were significantly improved. The general models with good predicting effect can be used for the rapid quality determination of Yaobitong capsule intermediates. 
		                        		
		                        		
		                        		
		                        	
6.The mechanism of effective traditional Chinese medicine components and prescriptions in treatment of chronic pancreatitis by intervening against pancreatic stellate cells
Ruyang CHENG ; Weining SONG ; Xin JIANG ; Yehao WANG ; Lin LIU ; Fang LU ; Shumin LIU
Journal of Clinical Hepatology 2025;41(4):793-800
		                        		
		                        			
		                        			Chronic pancreatitis (CP) is a chronic disease characterized by recurrent inflammation and progressive damage to pancreatic tissue, and its deterioration may increase the risk of pancreatic cancer in patients with CP, which seriously threatens the health of patients with CP. In recent years, studies on the pathogenesis of CP have mostly focused on the activation of pancreatic stellate cells (PSCs) and its role in pancreatic fibrosis. This article elaborates on the mechanism of action of PSCs in CP, summarizes the current status of research on effective traditional Chinese medicine components and prescriptions for intervention of PSCs in the treatment of chronic CP, and proposes the future research directions for effective traditional Chinese medicine components and prescriptions, so as to provide a reference for the clinical treatment of CP patients in the future. 
		                        		
		                        		
		                        		
		                        	
7.Application of Lycii Fructus and Its Compound Formulas in Central Nervous System Diseases: A Review
Ruyang CHENG ; Weining SONG ; Xin JIANG ; Yehao WANG ; Chi ZHANG ; Zhendong ZHANG ; Shumin LIU
Chinese Journal of Experimental Traditional Medical Formulae 2025;31(22):273-281
		                        		
		                        			
		                        			The pathogenesis of central nervous system (CNS) diseases is complex, seriously affecting patients' physical and mental health and imposing a heavy economic burden on society. Western medicine shows limited efficacy in treating CNS diseases and is often associated with numerous adverse reactions and contraindications. Chinese medicine Lycii Fructus exhibits multiple pharmacological effects, including immune regulation, enhancement of hematopoietic function, liver protection, anti-tumor, hypoglycemic, antipyretic, anti-aging, and anti-radiation activities, and has gradually been applied in clinical treatment. In recent years, the active components of Lycii Fructus have attracted considerable attention for their potential therapeutic effects on CNS diseases. Studies indicate that these active components may exert neuroprotective effects through anti-inflammatory and antioxidant actions, inhibition of neuronal apoptosis, and repair of neuronal damage, involving multiple targets and pathways. This review summarizes the therapeutic effects of Lycii Fructus active components in CNS diseases over the past decade by searching PubMed, CNKI, Wanfang Data, and other electronic databases, aiming to provide new treatment strategies and insights for future research on Lycii Fructus in CNS disorders. 
		                        		
		                        		
		                        		
		                        	
8.BMP7 expression in mammalian cortical radial glial cells increases the length of the neurogenic period.
Zhenmeiyu LI ; Guoping LIU ; Lin YANG ; Mengge SUN ; Zhuangzhi ZHANG ; Zhejun XU ; Yanjing GAO ; Xin JIANG ; Zihao SU ; Xiaosu LI ; Zhengang YANG
Protein & Cell 2024;15(1):21-35
		                        		
		                        			
		                        			The seat of human intelligence is the human cerebral cortex, which is responsible for our exceptional cognitive abilities. Identifying principles that lead to the development of the large-sized human cerebral cortex will shed light on what makes the human brain and species so special. The remarkable increase in the number of human cortical pyramidal neurons and the size of the human cerebral cortex is mainly because human cortical radial glial cells, primary neural stem cells in the cortex, generate cortical pyramidal neurons for more than 130 days, whereas the same process takes only about 7 days in mice. The molecular mechanisms underlying this difference are largely unknown. Here, we found that bone morphogenic protein 7 (BMP7) is expressed by increasing the number of cortical radial glial cells during mammalian evolution (mouse, ferret, monkey, and human). BMP7 expression in cortical radial glial cells promotes neurogenesis, inhibits gliogenesis, and thereby increases the length of the neurogenic period, whereas Sonic Hedgehog (SHH) signaling promotes cortical gliogenesis. We demonstrate that BMP7 signaling and SHH signaling mutually inhibit each other through regulation of GLI3 repressor formation. We propose that BMP7 drives the evolutionary expansion of the mammalian cortex by increasing the length of the neurogenic period.
		                        		
		                        		
		                        		
		                        			Animals
		                        			;
		                        		
		                        			Mice
		                        			;
		                        		
		                        			Humans
		                        			;
		                        		
		                        			Ependymoglial Cells/metabolism*
		                        			;
		                        		
		                        			Hedgehog Proteins/metabolism*
		                        			;
		                        		
		                        			Ferrets/metabolism*
		                        			;
		                        		
		                        			Cerebral Cortex
		                        			;
		                        		
		                        			Neurogenesis
		                        			;
		                        		
		                        			Mammals/metabolism*
		                        			;
		                        		
		                        			Neuroglia/metabolism*
		                        			;
		                        		
		                        			Bone Morphogenetic Protein 7/metabolism*
		                        			
		                        		
		                        	
9.Application of Animal Models of Corneal Neovascularization Based on Data Mining
Rikai ZHAO ; Huiyan YANG ; Ying LIU ; Xin JIANG ; Mingsan MIAO
Chinese Journal of Experimental Traditional Medical Formulae 2024;30(9):166-173
		                        		
		                        			
		                        			ObjectiveTo provide a reference for the establishment of an ideal corneal neovascularization (CNV) animal model by summarizing the modeling characteristics of CNV animal models. MethodWith "CVN" as the theme word, this paper searched the China National Knowledge Infrastructure (CNKI), Wanfang, Chinese medical journals full-text database, and PubMed database and screened out relevant literature on CNV animal experiments from 2013 to 2023. The database was established by Excel 2021, and the experimental animal strain, gender, modeling method, detection index, and application category were sorted out. The characteristics of the CNV animal model were analyzed. ResultAfter comparative analysis, it was found that the animal strains were Sprague-Dawley rats (87 times, 29.49%) and New Zealand white rabbits (52 times, 17.63%). Male animals were recommended. Most modeling methods for efficacy verification and mechanism studies were the alkali burn method. Index detection methods included apparent index observation, histopathological detection, immunohistochemistry (IHC), Western blot, and various polymerase chain reaction (PCR) tests. Detection indexes included apparent indication, corneal histopathology, CNV regulation, etc. ConclusionThe CNV model of SD rats induced by the alkali burn method is recommended for model replication, and the indexes are mainly selected from the growth of CNV, corneal histopathological test, and vascular endothelial growth factor (VEGF)-related test. In addition, according to the demand, the corneal apparent indication and the basic indexes related to the regulation of CNV, such as vascular endothelial growth factor receptor 2 (VEGFR2), basic fibroblast growth factor (bFGF), and secretogranin Ⅲ (Scg3) are also selected. Clinical treatment of CNV relies on anti-inflammatory drugs and anti-VEGF drugs, and there is a lack of application of traditional Chinese medicine (TCM), so the model needs to be improved by adding elements of TCM syndromes. 
		                        		
		                        		
		                        		
		                        	
10.Recent advances in small-molecule inhibitors targeting influenza virus RNA-dependent RNA polymerase
Hui-nan JIA ; Rui-fang JIA ; Ji-wei ZHANG ; Yuan-min JIANG ; Chuan-feng LIU ; Ying ZHANG ; Xin-yong LIU ; Peng ZHAN
Acta Pharmaceutica Sinica 2024;59(1):43-60
		                        		
		                        			
		                        			 Influenza virus causes serious threat to human life and health. Due to the inherent high variability of influenza virus, clinically resistant mutant strains of currently approved anti-influenza virus drugs have emerged. Therefore, it is urgent to develop antiviral drugs with new targets or mechanisms of action. RNA-dependent RNA polymerase is directly responsible for viral RNA transcription and replication, and plays key roles in the viral life cycle, which is considered an important target of anti-influenza drug design. From the point of view of medicinal chemistry, this review summarizes current advances in diverse small-molecule inhibitors targeting influenza virus RNA-dependent RNA polymerase, hoping to provide valuable reference for development of novel antiviral drugs. 
		                        		
		                        		
		                        		
		                        	
            
Result Analysis
Print
Save
E-mail